Disclosure Information

In accordance with the ACCME Accreditation Criteria, the American College of Surgeons must ensure that anyone in a position to control the content of the educational activity (planners and speakers/authors/discussants/moderators) has disclosed all financial relationships with any commercial interest (termed by the ACCME as “ineligible companies”, defined below) held in the last 24 months (see below for definitions). Please note that first authors were required to collect and submit disclosure information on behalf all other authors/contributors, if applicable.

Ineligible company
The ACCME defines an “ineligible company” as any entity producing, marketing, re-selling, or distributing health care goods or services used on or consumed by patients. Providers of clinical services directly to patients are NOT included in this definition.

Financial Relationships
Relationships in which the individual benefits by receiving a salary, royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as employment, management position, independent contractor (including contracted research), consulting, speaking and teaching, membership on advisory committees or review panels, board membership, and other activities from which remuneration is received, or expected.  

Conflict of Interest
Circumstances create a conflict of interest when an individual has an opportunity to affect CME content about products or services of an ineligible company with which he/she has a financial relationship.

The ACCME also requires that ACS manage any reported conflict and eliminate the potential for bias during the educational activity.  Any conflicts noted below have been managed to our satisfaction. The disclosure information is intended to identify any commercial relationships and allow learners to form their own judgments. However, if you perceive a bias during the educational activity, please report it on the evaluation.

Planning Committee Disclosures

Shanley B. Deal, MD, FACS, Course Chair - Associate Professor of General and Bariatric Surgery, Virginia Mason Franciscan Health; Seattle, WA
This planner/speaker has no relevant financial relationship(s) with ineligible companies to disclose.

George "Ryne" Marshall, MD, FACS, Course Co-Chair - Assistant Professor of Surgery, University of Louisville; Louisville, KY
This planner/speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Speakers/Faculty Disclosures

Vincent Athas, MD - Acute Care Surgery Fellow, University of Louisville; Louisville, KY
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Jeremy M. Badach, MD - SCC/ACS Fellow, University of Louisville; Louisville, KY
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Kristen Burke, MD - AAST Acute Care Surgery Fellow, University of Louisville; Louisville, KY
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Thomas A. Carver, MD, FACS - Professor of Acute Care Surgery, General Surgery, Trauma and Critical Care, Froedtert Hospital and the Medical College of Wisconsin; Milwaukee, WI
This speaker has financial relationships with 1) InnoVital, Inc. for research and received honorarium, and 2) Cytovale, Inc. for medical monitoring and received honorarium.

Gerald Cheadle, MD, RPVI - Assistant Professor of Surgery, The Hiram C. Polk, Jr., MD, Department of Surgery, University of Louisville School of Medicine Division of Vascular Surgery and Endovascular Therapeutics; Louisville, KY
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Nicole Christian, MD, MSCS, FACS - Associate Professor of Surgery, Breast Surgical Oncology, University of Colorado School of Medicine; Aurora, CO
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Christine Chung, DO - General and Hepatopancreaticobiliary Surgery, Kaiser Permanente; Sacramento, CA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Trevor D. Crafts, MD - Assistant Professor of Surgery, Rocky Mountain Regional VAMC and The University of Colorado, Anschutz Medical Center; Denver, CO
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Simin Golestani, MD - Acute Care Surgery Fellow, Froedtert Hospital and the Medical College of Wisconsin; Milwaukee, WI
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Kristy Hawley, MD, MPH - Assistant Professor of Surgery, University of Colorado School of Medicine; Aurora, CO
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Whitney R. Jenson, MD, MPH, FACS - Assistant Professor of Surgery, University of Colorado; Aurora, CO
This speaker has a financial relationship with Eli Lily as a stockholder and received dividends.

Paul M. Jeziorczak, MD, MPH, FACS, FAAP - Visiting Clinical Associate Professor of Surgery and Pediatrics, OSF Children’s Hospital of Illinois and University of Illinois College of Medicine; Peoria, IL
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Edward L. Jones, II, MD, MS, FACS, FASGE - Chief of Surgery, Rocky Mountain Regional VAMC; Associate Professor of Surgery, University of Colorado; Denver, CO
This speaker has a financial relationship with Boston Scientific for speaking and received consulting fees.

Jennifer A. Kaplan, MD, MAS, FACS - Colorectal Surgery, Virginia Mason Franciscan Health; Seattle, WA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Brenessa M. Lindeman, MD, MEHP, FACS, MAMSE - Associate Professor of Surgery, Pediatrics, and Medical Education; Assistant Dean for Graduate Medical Education; Vice Chair of Education, Department of Surgery; Section Chief and Fellowship Director, Endocrine Surgery; University of Alabama at Birmingham; Birmingham, AL
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

William "Aaron" Marshall, MD, FACS - Assistant Professor of Surgery, University of Colorado Anschutz Medical Center; Aurora, CO
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Brooks Ohlson, MD - Anesthesiologist/Intensivist; Program Director, Anesthesiology Residency, Virginia Mason Franciscan Health; Seattle, WA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Alexander C. Schwed, MD, FACS - Assistant Professor of Surgery, Harbor-UCLA Medical Center; Torrance, CA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Vlad V. Simianu, MD, MPH, FACS - Medical Director, Colon and Rectal Disorders, Center for Digestive Health, Virginia Mason Franciscan Health; Seattle, WA
This speaker has financial relationships with 1) BD Surgical for his role on the Colorectal Advisory Board and received honorarium, and 2) Intuitive Surgical for speaking and received honorarium.

Hillary Simon, DO - Assistant Professor of Surgery, University of Louisville; Louisville, KY
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Erik Stiles, MD - General Surgery Resident PGY4, Virginia Mason Franciscan Health; Seattle, WA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Cristian D. Valenzuela, MD - Assistant Professor of Surgery, Division of Surgical Oncology, Department of Surgery, Oregon Health & Science University; Portland, OR
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.

Lauren Wancata, MD - General and Hepatopancreaticobiliary Surgery, Virginia Mason Franciscan Health; Seattle, WA
This speaker has no relevant financial relationship(s) with ineligible companies to disclose.